BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18345610)

  • 1. Synthesis and evaluation of novel polyaminocarboxylate-based antitumor agents.
    Chong HS; Ma X; Lee H; Bui P; Song HA; Birch N
    J Med Chem; 2008 Apr; 51(7):2208-15. PubMed ID: 18345610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a class of 1,4,7-triazacyclononane derivatives as iron depletion antitumor agents.
    Wang S; Gai Y; Zhang S; Ke L; Ma X; Xiang G
    Bioorg Med Chem Lett; 2018 Jan; 28(2):117-121. PubMed ID: 29233652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging.
    Kang CS; Ren S; Sun X; Chong HS
    ChemMedChem; 2016 Oct; 11(19):2188-2193. PubMed ID: 27624789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of Polyaminocarboxylate Ligand-Based Theranostic Conjugates for Antibody-Targeted Cancer Therapy and Near-Infrared Optical Imaging.
    Ren S; Sun X; Wang H; Nguyen TH; Sadeghipour N; Xu X; Kang CS; Liu Y; Xu H; Wu N; Chen Y; Tichauer K; Minh DDL; Chong HS
    ChemMedChem; 2018 Dec; 13(24):2606-2617. PubMed ID: 30403833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
    Chong HS; Song HA; Ma X; Milenic DE; Brady ED; Lim S; Lee H; Baidoo K; Cheng D; Brechbiel MW
    Bioconjug Chem; 2008 Jul; 19(7):1439-47. PubMed ID: 18564868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.
    Kang CS; Wu N; Chen Y; Sun X; Bandara N; Liu D; Lewis MR; Rogers BE; Chong HS
    J Inorg Biochem; 2016 Jan; 154():60-6. PubMed ID: 26583705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development.
    De Silva RA; Jain S; Lears KA; Chong HS; Kang CS; Sun X; Rogers BE
    Nucl Med Biol; 2012 Nov; 39(8):1099-104. PubMed ID: 22743158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid-based polyaminocarboxylate conjugates as targeted antitumor agents.
    Chong HS; Song HA; Ma X; Lim S; Sun X; Mhaske SB
    Chem Commun (Camb); 2009 Jun; (21):3011-3. PubMed ID: 19462070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective total synthesis of a novel regiomer of herbarumin I and its cytotoxic and antimicrobial activities.
    Jangili P; Kashanna J; Kumar CG; Poornachandra Y; Das B
    Bioorg Med Chem Lett; 2014 Jan; 24(1):325-7. PubMed ID: 24300737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of C20-substituted derivative of pregnenolone acetate with copper (II) leads to ROS generation, DNA cleavage and apoptosis in cervical cancer cells: Therapeutic potential of copper chelation for cancer treatment.
    Zafar A; Singh S; Ahmad S; Khan S; Imran Siddiqi M; Naseem I
    Bioorg Chem; 2019 Jun; 87():276-290. PubMed ID: 30908970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with
    Chong HS; Chen Y; Kang CS; Sin I; Zhang S; Wang H
    J Inorg Biochem; 2021 Aug; 221():111436. PubMed ID: 33971521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
    Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
    ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient synthesis and evaluation of bimodal ligand NETA.
    Chong HS; Song HA; Birch N; Le T; Lim S; Ma X
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3436-9. PubMed ID: 18445528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological properties of iron chelators based on a bis-2-(2-hydroxy-phenyl)-thiazole-4-carboxamide or -thiocarboxamide (BHPTC) scaffold.
    Rodriguez-Lucena D; Gaboriau F; Rivault F; Schalk IJ; Lescoat G; Mislin GL
    Bioorg Med Chem; 2010 Jan; 18(2):689-95. PubMed ID: 20036563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives).
    Hayat F; Salahuddin A; Zargan J; Azam A
    Eur J Med Chem; 2010 Dec; 45(12):6127-34. PubMed ID: 20961670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of
    Satpati D; Sharma R; Sarma HD; Dash A
    Chem Biol Drug Des; 2018 Mar; 91(3):781-788. PubMed ID: 29130625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma.
    Brard L; Granai CO; Swamy N
    Gynecol Oncol; 2006 Jan; 100(1):116-27. PubMed ID: 16203029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents III: the effect of the ligands on molecular targets involved in proliferation.
    Darnell G; Richardson DR
    Blood; 1999 Jul; 94(2):781-92. PubMed ID: 10397746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.